Article
A recessive variant of XRCC4 predisposes to non- BRCA1/2 breast cancer in chinese women and impairs the DNA damage response via dysregulated nuclear localization.
Oncotarget - 15 Dec 2014
He Min, Hu Xin, Chen Li, Cao A-Yong, Yu Ke-Da, Shi Ting-Yan, Kuang Xia-Ying, Shi Wen-Biao, Ling Hong, Li Shan, Qiao Feng, Yao Ling, Wei Qingyi, Di Gen-Hong, Shao Zhi-Ming
Abstract excerpt
XRCC4 plays a crucial role in the non-homologous end joining pathway that maintains genome stability. In this two-stage case-control study with 1,764 non-BRCA1/2 breast cancer patients and 1,623 cancer-free controls, we investigated the contribution of genetic variants of XRCC4 to breast cancer s...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
